VI
AVDL

Versor Investments’s Avadel Pharmaceuticals AVDL Stock Holding History

Versor Investments’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-244,019
Closed -$5.26M – 86
2025
Q4 		$5.26M Buy
+244,019
New +$4.74M 0.82% 21

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Versor Investments's AVDL Position: Q1 2026 in Review

Versor Investments sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 244,019 shares — an estimated $5.26M sold.

Versor Investments first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $5.26M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Versor Investments reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Versor Investments sold 244,019 Avadel Pharmaceuticals shares in Q1 2026, an estimated $5.26M.
  • Versor Investments first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Versor Investments's Avadel Pharmaceuticals position peaked at $5.26M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Versor Investments's 13F filing for Q1 2026, filed 12 May 2026.